Bridgeway Capital Management’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1K | Hold |
|
|||||
|
2025
Q1 | $9.61K | Hold |
|
|||||
|
2024
Q4 | $13K | Buy |
|
|||||
|
2024
Q3 | $29.9K | Buy |
|
|||||
|
2024
Q2 | $44K | Sell |
|
|||||
|
2024
Q1 | $488K | Sell |
|
|||||
|
2023
Q4 | $911K | Buy |
|
|||||
|
2023
Q3 | $862K | Buy |
|
|||||
|
2023
Q2 | $1.76M | Buy |
|
|||||
|
2023
Q1 | $58.9K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $106K | Hold |
|
|||||
|
2022
Q2 | $203K | Hold |
|
|||||
|
2022
Q1 | $151K | Hold |
|
|||||
|
2021
Q4 | $204K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $3.29M | Sell |
|
|||||
|
2021
Q1 | $2.18M | Hold |
|
|||||
|
2020
Q4 | $1.13M | Hold |
|
|||||
|
2020
Q3 | $1.17M | Sell |
|
|||||
|
2020
Q2 | $665K | Buy |
|
|||||
|
2020
Q1 | $234K | Hold |
|
|||||
|
2019
Q4 | $434K | Buy |
|
|||||
|
2019
Q3 | $254K | Buy |
|
|||||
|
2019
Q2 | $300K | Hold |
|
|||||
|
2019
Q1 | $206K | Buy |
|
|||||
|
2018
Q4 | $142K | Hold |
|
|||||
|
2018
Q3 | $215K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $53K | Hold |
|
|||||
|
2017
Q3 | $103K | Hold |
|
|||||
|
2017
Q2 | $102K | Hold |
|
|||||
|
2017
Q1 | $143K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $16K | Hold |
|
|||||
|
2015
Q4 | $151K | Hold |
|
|||||
|
2015
Q3 | $121K | Hold |
|
|||||
|
2015
Q2 | $141K | Buy |
|
|||||
|
2015
Q1 | $167K | Sell |
|
|||||
|
2014
Q4 | $419K | Buy |
|
|||||
|
2014
Q3 | $184K | Buy |
|